ethosuximide has been researched along with formaldehyde in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CC; Cheng, JK; Chiou, LC; Lin, CS; Yang, JR | 1 |
Abignente, E; Curcio, A; De Chiaro, M; de Novellis, V; Guida, F; Maione, S; Marabese, I; Melisi, D; Palazzo, E; Rimoli, MG; Rossi, F | 1 |
2 other study(ies) available for ethosuximide and formaldehyde
Article | Year |
---|---|
Effects of intrathecal injection of T-type calcium channel blockers in the rat formalin test.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; Dose-Response Relationship, Drug; Ethosuximide; Formaldehyde; Hindlimb; Injections, Spinal; Long-Term Potentiation; Male; Mibefradil; Neural Inhibition; Neuronal Plasticity; Nickel; Nociceptors; Pain Threshold; Rats; Rats, Sprague-Dawley; Spinal Cord | 2007 |
Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect.
Topics: Action Potentials; Analgesics; Animals; Anticonvulsants; Blood Pressure; Dose-Response Relationship, Drug; Ethosuximide; Formaldehyde; Heart Rate; Male; Medulla Oblongata; Microinjections; Neurons; Pain; Pain Measurement; Periaqueductal Gray; Pyridines; Rats; Rats, Wistar; Reaction Time; Time Factors | 2010 |